Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost

In CD34+ cells mobilization of patients with multiple myeloma (MM), the use of Cyclophosphamide (CTX) at a dose of 2 g/m(2) has low efficacy although also lower toxicity. The suboptimal mobilizing effect of low-dose CTX, however, may be overcome by plerixafor (PLX) on demand. We conducted a prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Milone, Giuseppe, Conticello, Concetta, Leotta, Salvatore, Michieli, Maria Grazia, Martino, Massimo, Marco, Anna Lia Di, Spadaro, Andrea, Cupri, Alessandra, Condorelli, Annalisa, Milone, Giulio Antonio, Markovic, Uros, Sciortino, Roberta, Schininà, Giovanni, Moschetti, Gaetano, Villari, Loredana, Saccardi, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649636/
https://www.ncbi.nlm.nih.gov/pubmed/33204611
http://dx.doi.org/10.1016/j.lrr.2020.100227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649636/
https://www.ncbi.nlm.nih.gov/pubmed/33204611
http://dx.doi.org/10.1016/j.lrr.2020.100227

Ejemplares similares